RALA antibody | knockout validation | Abcam ab126627

This is a knockout-validated antibody summary, based on the publication "The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

RALA antibody | knockout validation | Abcam ab126627 figure 1
Figure 1. Representative images of RALA and RALB immunofluorescence staining in MDA-MB-231 Ctrl, RALA-KO and RALB-KO cells (red = RALA or RALB, blue = DAPI; scale bars = 20μm). From [1].
Antibody information

Rabbit monoclonal IgG

Company: Abcam

Antibody: RALA

Catalog number: ab126627

Summary: Rabbit monoclonal antibody against a synthetic peptide within human RALA (aa 100-200). Reacts with human. Suitable for western blot, immunohistochemistry (paraffin) and flow cytometry. Unsuitable for immunoprecipitation or immunocytochemistry/immunofluorescence.

Validation Method

Immunocytochemistry

Sample

Control and RALA-KO MDA-MB-231 cells.

Blocking agent

5% BSA-0.3% Triton x-100 solution.

Primary incubation

1:200 dilution in blocking buffer overnight at 4°C.

Secondary incubation

1:250 dilution AlexaFluor 594 anti-rabbit secondary antibody (Invitrogen, A21207) for 1h at room temperature.

Detection

Zeiss LSM 800 confocal microscope.

References
  1. Thies K, Cole M, Schafer R, Spehar J, Richardson D, Steck S, et al. The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer. Breast Cancer Res. 2021;23:65 pubmed publisher